A former Roman Catholic monk has filed a federal lawsuit seeking unspecified damages against cosmetics giant L’Oreal, accusing the company of stealing patented technology in an antiaging wrinkle cream that his charity was selling to raise money for the poor. Dennis Wyrzykowski and his company, Carmel Laboratories LLC, have been joined in the lawsuit by the University of Massachusetts Medical School, which developed the technology and licensed it to Carmel in 2009. According to the lawsuit, the cream, called Easeamine, is made using technology inspired by a discovery by two UMass scientists that adenosine, a chemical compound found in the heart, can promote skin elasticity.
NYS Entity Status
NYS Filing Date
NOVEMBER 18, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - CHINA IMPORT FORMULA, LLC
Around the Web
- Former monk sues L’Oreal over antiaging formula
By Pat Eaton-Robb - Wednesday Aug 30, 2017
- H&M's Old Formula Needs a New Look
Thursday Sep 28, 2017
Fashion retailing giant H&M has opened over 40 new stores this year in the U.S. and China, the two markets shifting most rapidly online.
- China Will No Longer Accept Key North Korean Imports Following The U.N.’s New Sanctions
By emmieodea - Monday Aug 14, 2017
China is cutting off a huge portion of its trade with North Korea, but President Trump still thinks Beijing is being uncooperative.
- Art Review: From China’s Artist-Activist, a Citywide Great Wall
By JASON FARAGO - Thursday Oct 12, 2017
Ai Weiwei has endured frequent gripes that his activism has got the better of his art. That gripe is unfounded.
- Charter Airline Dynamic International Airways Files for Bankruptcy
Wednesday Jul 19, 2017
Charter carrier Dynamic International Airways LLC, which offers charter flights to regional cities in China, filed for bankruptcy protection Wednesday to stabilize its business.
- China Greenlights Imports of Two New GMO Products
Thursday Jun 15, 2017
China has approved imports of two new varieties of genetically modified crops, clearing the way for U.S. agricultural companies to market new biotech seeds to farmers.